LodeHQ
AI news for people who shipFree, by email

India Business · Friday, 19 June 2026 · Issue 17 · 10 stories

Accenture cut sinks IT stocks, Reliance bets on AI

Markets & Indices

Companies & Earnings

CDSCO bans HealthCare Global’s ethics panel, halting new trials for two years

India's drug regulator CDSCO has barred the Ethics Committee of HealthCare Global Enterprises for two years, halting all new clinical trials at its Bengaluru cancer institute. The ban follows uncovered deaths and undisclosed adverse events between 2021‑2025, and the hospital must compensate victims' families. This sidelines a KKR‑backed hospital chain from a key growth engine.

freepressjournal.in ↗2 min read at source

Economy & Policy

Banking & Finance

Global Cues & Commodities

You’re caught up.

That was all 10 stories in the 19 June issue.